Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Immunology
Volume 2015, Article ID 524507, 4 pages
http://dx.doi.org/10.1155/2015/524507
Case Report

Successful Desensitization of a Patient with Rituximab Hypersensitivity

1Department of Hematology, Ankara University, Cebeci, 06590 Ankara, Turkey
2Department of Pulmonary Medicine, Immunology and Allergy Clinic, Ankara University, Cebeci, 06590 Ankara, Turkey

Received 8 November 2014; Revised 1 January 2015; Accepted 1 January 2015

Academic Editor: Ahmad M. Mansour

Copyright © 2015 Pinar Ataca et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. I. Hong, L. Bankova, K. N. Cahill, T. Kyin, and M. C. Castells, “Allergy to monoclonal antibodies: cutting-edge desensitization methods for cutting-edge therapies,” Expert Review of Clinical Immunology, vol. 8, no. 1, pp. 43–54, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Castells, M. D. C. Sancho-Serra, and M. Simarro, “Hypersensitivity to antineoplastic agents: mechanisms and treatment with rapid desensitization,” Cancer Immunology, Immunotherapy, vol. 61, pp. 1575–1584, 2012. View at Publisher · View at Google Scholar
  3. P. J. Brennan, T. Rodriguez Bouza, F. I. Hsu, D. E. Sloane, and M. C. Castells, “Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment,” Journal of Allergy and Clinical Immunology, vol. 124, no. 6, pp. 1259–1266, 2009. View at Publisher · View at Google Scholar
  4. M. C. Castells, N. M. Tennant, D. E. Sloane et al., “Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases,” Journal of Allergy and Clinical Immunology, vol. 122, no. 3, pp. 574–580, 2008. View at Publisher · View at Google Scholar
  5. J. A. Meyerhardt, A. S. LaCasce, M. C. Castells, and H. Burstein, “Infusion reactions to therapeutic monoclonal antibodies used for cancer therapy,” http://www.uptodate.com/contents/infusionreactions-to-therapeutic-monoclonalantibodies-used-for-cancertherapy.
  6. Rituxan (package insert), South San Francisco, Calif, USA: Biogen Idec and Genentech, 2013.
  7. S. G. A. Brown, “Clinical features and severity grading of anaphylaxis,” Journal of Allergy and Clinical Immunology, vol. 114, no. 2, pp. 371–376, 2004. View at Publisher · View at Google Scholar
  8. P. J. Brennan, T. Rodriguez Bouza, F. I. Hsu, D. E. Sloane, and M. C. Castells, “Hypersensitivityreaction to mAb: 105 desensitizations in 23 patients, from evaluation to treatment,” Journal of Allergy and Clinical Immunology, vol. 124, pp. 1259–1266, 2009. View at Google Scholar
  9. P. J. Bugelski, R. Achuthanandam, R. J. Capocasale, G. Treacy, and E. Bouman-Thio, “Monoclonal antibody-induced cytokine-release syndrome,” Expert Review of Clinical Immunology, vol. 5, no. 5, pp. 499–521, 2009. View at Publisher · View at Google Scholar
  10. E. Schmidt, K. Hennig, C. Mengede, D. Zillikens, and A. Kromminga, “Immunogenicity of rituximab in patients with severe pemphigus,” Clinical Immunology, vol. 132, no. 3, pp. 334–341, 2009. View at Publisher · View at Google Scholar
  11. H. S. Kulkarni and P. M. Kasi, “Rituximab and cytokine release syndrome,” Case Reports in Oncology, vol. 5, no. 1, pp. 134–141, 2012. View at Publisher · View at Google Scholar
  12. A. Vultaggio, E. Maggi, and A. Matucci, “Immediate adverse reactions to biological: from pathogenic mechanisms to prophylactic management,” Current Opinion in Allergy and Clinical Immunology, vol. 11, no. 3, pp. 262–268, 2011. View at Publisher · View at Google Scholar
  13. P. Lieberman and M. Castells, “Desensitization to chemotherapeutic agents,” The Journal of Allergy and Clinical Immunology, vol. 2, no. 1, pp. 116–117, 2014. View at Publisher · View at Google Scholar
  14. A. Liu, L. Fanning, H. Chong et al., “Desensitization regimens for drug allergy: state of the art in the 21st century,” Clinical & Experimental Allergy, vol. 41, no. 12, pp. 1679–1689, 2011. View at Google Scholar